Researchers suggest discovery of genetic link between ASD and DM1 opens up potential new therapeutic avenues for ASD.

(NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to ...

Scientists from The Hospital for Sick Children (SickKids) and the University of Las Vegas, Nevada (UNLV) have uncovered a ...

The global molecular diagnostic market size is projected to increase from USD 368.53 million in 2025 and is estimated to be ...

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, presented new data at the Precision Med TRI-CON conference. The data supports an innovative ...